Vizgen

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• SBSeth BensonExecutive Officer
• RCRobert CarsonDirector · Executive Officer
• KCKeith CrandellDirector
• MDMarijn DekkersDirector
• DGDr. Philip GardellaExecutive Officer
• PGPhilip GardellaExecutive Officer
• CGChris GuiffreExecutive Officer
• DHDr. Jiang HeExecutive Officer
• AJAndrea JacksonDirector
• SLSimona LeviExecutive Officer
• TLTerry LoDirector · Executive Officer
• MPMatthew PosardDirector
• CUChristian UhrichDirector
• CUChristian UrhichDirector
• DWDavid WaltDirector
• DWDr. Peidong WangDirector · Executive Officer

• 02 Jul 2026Compositions And Methods For Improved Multiplexed Error Robust Fluorescence In Situ Hybridizationapplication
• 11 Sept 2025Compositions And Methods For Improved Multiplexed Error Robust Fluorescence In Situ Hybridizationapplication
• 08 May 2025Anchored Primary Nucleic Acid Probes And Methods Thereof; Ribonuclease-insensitive Methods For Determining Cellular Nucleic Acid In A Biological Sampleapplication
• 07 Sept 2023Methods Of Anchoring Fragmented Nucleic Acid Targets In A Polymer Matrix For Imagingapplication
• —Anchored Primary Nucleic Acid Probes And Methods Thereof; Ribonuclease-insensitive Methods For Determining Cellular Nucleic Acid In A Biological Sampleapplication
• —Methods Of Anchoring Fragmented Nucleic Acid Targets In A Polymer Matrix For Imagingapplication
• —Methods Of Determining Nucleic Acid Targets In Tissue Samplesapplication
• —Methods Of Determining Nucleic Acid Targets In Tissue Samplesapplication
• —Compositions And Methods For Improved Multiplexed Error Robust Fluorescence In Situ Hybridizationapplication
• —Anchored Primary Nucleic Acid Probes And Methods Thereof; Ribonuclease-insensitive Methods For Determining Cellular Nucleic Acid In A Biological Sampleapplication
• —Compositions And Methods For Improved Multiplexed Error Robust Fluorescence In Situ Hybridizationapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.